Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-KRT16 Antibody (R3B39)

Catalog #:   RHC36403 Specific References (11) DATASHEET
Host species: Mouse
Isotype: IgG1
Applications: IHC, WB
Accession: P08779
Overview

Catalog No.

RHC36403

Species reactivity

Human, Mouse, Rat

Host species

Mouse

Isotype

IgG1

Clonality

Monoclonal

Tested applications

IHC: 1:50-1:100, WB: 1:500-1:1000

Target

Keratin, type I cytoskeletal 16, KRT16A, Keratin-16, CK-16, Cytokeratin-16, KRT16, K16

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P08779

Applications

IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.5% BSA, 0.05% Sodium Azide and 50% Glycerol.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

R3B39

Data Image
  • Immunohistochemical
    Immunohistochemistry analysis of paraffin-embedded Human gullet cancer tissue using CK16 antibody.High-pressure and temperature Sodium Citrate pH 6.0 was used for antigen retrieval.
  • Western blot
    Western blot analysis of Cytokeratin 16 in T47D and Hela lysates using Cytokeratin 16 antibody.
References

Identifying transcriptomic predictors of brodalumab response in psoriasis using CART analysis., PMID:40140063

Five hub genes contributing to the oncogenesis and trastuzumab-resistance in gastric cancer., PMID:36202277

Development and characterization of a human Th17-driven ex vivo skin inflammation model., PMID:32737987

Short-term transcriptional response to IL-17 receptor-A antagonism in the treatment of psoriasis., PMID:31883845

A novel miR-365-3p/EHF/keratin 16 axis promotes oral squamous cell carcinoma metastasis, cancer stemness and drug resistance via enhancing β5-integrin/c-met signaling pathway., PMID:30782177

Omalizumab normalizes the gene expression signature of lesional skin in patients with chronic spontaneous urticaria: A randomized, double-blind, placebo-controlled study., PMID:29974963

Neuropeptide regulation of adaptive immunity in the tibia fracture model of complex regional pain syndrome., PMID:29642930

Anthralin modulates the expression pattern of cytokeratins and antimicrobial peptides by psoriatic keratinocytes., PMID:28673488

Assessment of Anti-TNF-α Activities in Keratinocytes Expressing Inducible TNF- α: A Novel Tool for Anti-TNF-α Drug Screening., PMID:27415000

Changes in keratin expression during metastatic progression of breast cancer: impact on the detection of circulating tumor cells., PMID:22228641

Innate immune modulation of keratinocytes by antikeratin 16 antibodies., PMID:18557933

Datasheet

Document Download

Anti-KRT16 Antibody (R3B39).pdf

 

$ 220
Product specifications
50 μg 220 100 μg 350

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-KRT16 Antibody (R3B39) [RHC36403]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only